일회용 산소 마스크 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the disposable oxygen masks market size was valued at USD 1.5 billion in 2025 and is estimated to grow from USD 1.61 billion in 2026 to reach USD 2.46 billion by 2031, at a CAGR of 8.88% during the forecast period (2026-2031).

Global Disposable Oxygen Masks Market Trends and Insights

Rising Respiratory Disease and Acute-Care Demand

Chronic respiratory disease creates a continuing need for oxygen delivery interfaces across acute and long-term care settings. Chronic respiratory diseases caused 569.2 million prevalent cases and 4.2 million deaths worldwide in 2023, while COPD caused 3.4 million deaths. COPD was also identified as the third leading cause of death, which supports a durable clinical need for oxygen therapy. In the WHO South-East Asia Region, COPD moved from the seventh leading cause of death in 2000 to the fourth in 2021. This change shifts more potential volume toward health systems that are still building standardized procurement systems for disposable respiratory supplies, including purchasing processes that must balance clinical standards, predictable replenishment, local distribution capacity, and public budget limits across hospital and community settings. The disposable oxygen masks market is therefore linked to both established hospital demand and the developing respiratory-care capacity of lower- and middle-income countries.

Expansion of Home-Based Oxygen Therapy

Home oxygen coverage under Medicare can apply beyond standard hypoxemia thresholds in defined clinical circumstances, which supports care outside inpatient facilities. This setting changes the pattern of use because patients and suppliers manage recurring replenishment rather than a hospital's intermittent bulk order cycle, making service continuity, delivery coordination, and readily available replacement products important parts of routine care for homecare users nationwide each day without disruption. Homecare is forecast to grow at an 8.8% CAGR through 2031, making it the fastest-growing end-user setting in the disposable oxygen masks market. Home delivery and durable medical equipment channels can make replacement purchasing more regular for people who use oxygen therapy daily. Publicly supported care programs in India and China add another potential demand layer for home respiratory care, although procurement practices differ by location. The shift makes channel execution as important as product availability for suppliers serving the disposable oxygen masks market, because delivery schedules, prescription documentation, patient education, and coordination with durable medical equipment providers influence whether a product reaches the user on time.

Substitution by Nasal Cannulas and High-Flow Nasal Cannula Systems

High-flow nasal cannula use has grown in monitored settings for people with acute respiratory failure. Episodes at large U.S. health systems rose from 176 per month in early 2017 to 269 per month by late 2024. This modality competes most directly with conventional masks in intensive-care and step-down environments that need humidified high-flow oxygen, where the clinical objective, monitoring resources, and staffing model can support a more complex form of respiratory intervention than is typically used in a standard emergency, ward, or homecare encounter. A 2025 study found that ward-based use remained limited outside monitored areas because of equipment cost, titration requirements, and concerns about delayed recognition of therapy failure. Standard masks retain practical value in emergency departments, surgical care, general wards, and ambulatory care, where rapid setup and low cost matter. The restraint is concentrated in higher-acuity locations rather than across the entire disposable oxygen masks market, because conventional masks remain easier to deploy where staff need a familiar interface that requires limited equipment, setup time, and specialized monitoring.

Other drivers and restraints analyzed in the detailed report include:

1. Infection-Control Preference for Single-Use Interfaces
2. Hospital and Emergency-Care Capacity Expansion
3. Reimbursement and Tender-Price Pressure in Homecare

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Simple oxygen masks held 38.5% of the disposable oxygen masks market share in 2026, the largest position among product types. Hospitals keep these masks in large quantities for emergency readiness, routine oxygen supplementation, and multi-ward protocols. Their familiar design and low deployment burden support steady institutional purchasing. Rebreather masks address applications where recirculation of inspired gas is clinically appropriate. Venturi masks are used when more precise fraction of inspired oxygen control is required, including care for COPD where uncontrolled oxygen delivery may create clinical risk. Specialty masks are forecast to grow at a 7.8% CAGR through 2031, reflecting demand for more differentiated functions.

Specialty configurations include products with carbon dioxide monitoring ports, combined aerosol and oxygen capability, and scavenging functions for post-anesthesia care. The disposable oxygen masks market size for specialty masks benefits when a single interface can replace a separate monitoring or delivery step. Vyaire Medical's AirLife Open Et mask received FDA 510(k) clearance in November 2024 as a disposable low-flow oxygen mask that integrates end-tidal carbon dioxide monitoring. Purchasing teams can favor these designs because they reduce formulary complexity and support consistent clinical setups. Intersurgical reported a 2026 peer-reviewed study in which its EcoLite high-concentration mask delivered 15-27% higher oxygen concentrations than a conventional comparator under standardized parameters. The study attributed the result to one-way valve function, reservoir-bag volume, and improved facial seal, showing why clinical evidence can influence specialty-mask decisions when respiratory therapy teams compare oxygen-delivery consistency, patient fit, device functionality, and the operational value of an integrated design.

PVC held 58.4% of the disposable oxygen masks market share in 2026, supported by cost advantages and validated manufacturing capacity. It remains widely used for standard oxygen-mask designs because suppliers and healthcare buyers are familiar with its processing and performance characteristics. PVC also supports high-volume production for institutional tenders that prioritize dependable supply and cost control. Silicone is forecast to expand at an 8.2% CAGR through 2031. It is used where extended-wear tolerance, neonatal use, or patient-contact specifications require a different material profile. The segment reflects a gradual material shift rather than a rapid replacement of PVC across all mask designs, since manufacturers must validate material performance, retain appropriate production capacity, maintain availability for existing buyers, and meet different regional compliance expectations.

The European Commission extended the DEHP sunset date for medical devices to July 1, 2030 under Regulation (EU) 2023/2482. This deadline defines a compliance window for producers that use legacy DEHP-plasticized PVC in products sold in Europe, requiring them to consider material qualification, technical documentation, manufacturing validation, supplier readiness, and the timing of product changes before the regulatory horizon becomes more immediate. The disposable oxygen masks market size for silicone may gain support as manufacturers qualify alternative materials before that date. North American suppliers work under a different regulatory context, while California has stricter requirements beginning in 2030. Input supply is important because medical-grade silicone is produced by a limited group of vertically integrated suppliers. Rubber and other elastomers remain relevant in smaller specialty uses where neither standard PVC economics nor silicone specifications determine the material choice, giving suppliers a limited but stable option for designs with particular fit, performance, or application requirements.

Complete Report Scope:

• Segmentation by Product Type
  • Simple Oxygen Masks
  • Rebreather Masks
  • Venturi Masks
  • Specialty Oxygen Masks
• Segmentation by Material
  • Polyvinyl Chloride
  • Silicone
  • Others (Rubber and Elastomer)
• Segmentation by Application
  • Respiratory Disorders
  • Emergency & Critical Care
  • Surgical Care
  • Aerosol Therapy
• Segmentation by End User
  • Hospitals & Clinics
  • Homecare
  • Emergency Services
  • Other Healthcare Facilities
• Segmentation by Distribution Channel
  • Direct Sales
  • Retail
  • Online Stores
• Segmentation by Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 35.4% of the disposable oxygen masks market share in 2025. The region combines hospital capacity, Medicare home-oxygen coverage, and single-use requirements that support consumption per patient encounter, while its established provider networks, purchasing organizations, and durable medical equipment channels create a setting in which suppliers can serve both hospital demand and the recurring needs of home-based oxygen users. U.S. hospital construction starts reached USD 33.9 billion in 2024 and are projected at USD 30.7 billion in 2026. New facilities establish formularies and supply agreements before opening, which can support future respiratory-consumable demand. Canada adds demand through provincial procurement that favors established contracted suppliers. Mexico contributes through expansion across the IMSS hospital network, where additional institutional activity can broaden the regional demand base for routine acute-care respiratory supplies and support procurement of standard oxygen-delivery interfaces.

Europe is the second-largest regional setting, with Germany, the United Kingdom, and France supported by national hospital supply contracts and home-oxygen programs. The region's procurement systems make price, compliance, and dependable supply important to the disposable oxygen masks market. Asia-Pacific is forecast to grow at an 8.1% CAGR through 2031, the fastest regional rate. Chronic respiratory diseases account for 12% of deaths in the WHO South-East Asia Region. China is the region's largest national setting, while India is supported by subsidized care and local medical-device manufacturing measures. Japan, South Korea, and Australia have more mature home-respiratory-care needs shaped by aging populations, subsidy programs, and regulatory requirements, which can favor suppliers able to meet established quality expectations and serve home-based patients through organized care channels.

The Middle East and Africa has a split demand profile. Saudi Arabia and the United Arab Emirates are building hospital infrastructure that requires compliant single-use respiratory products. South Africa and other sub-Saharan markets have less institutional capacity but can generate demand through acute-care programs and emergency stockpiles. South America is concentrated in Brazil and Argentina, where public systems manage substantial COPD and asthma needs under cost-sensitive purchasing budgets. Brazil's respiratory-care programs support volumes that remain focused on lower-cost simple masks. In emerging settings, the disposable oxygen masks market favors suppliers that can combine compliance, cost control, and sufficient distribution coverage, since affordable products must still reach hospitals and community settings with appropriate documentation, consistent quality, and dependable local supply.

1. Medline Industries
2. Teleflex
3. Intersurgical Ltd.
4. Flexicare
5. Dynarex
6. VYAIRE MEDICAL, INC.
7. Ambu
8. Drive DeVilbiss Healthcare
9. Besmed Health Business
10. HEYER Medical AG
11. BLS Systems Limited
12. Cardinal Health
13. Beckton Dickinson
14. ICU Medical
15. Dragerwerk AG and Co. KGaA
16. Fisher & Paykel Healthcare
17. Polymed Medical Devices
18. GaleMed Corporation
19. PFM medical AG
20. Airways Surgical Pvt. Ltd.
21. Armstrong Medical Ltd.
22. Mercury Medical
23. SunMed, LLC
24. Convatec
25. Zoll Medical
26. Masimo
27. Koninklijke Philips
28. Medtronic
29. Resmed

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Respiratory Disease and Acute-Care Demand
  • 4.2.2 Expansion of Home-Based Oxygen Therapy
  • 4.2.3 Infection-Control Preference for Single-Use Interfaces
  • 4.2.4 Hospital and Emergency-Care Capacity Expansion
  • 4.2.5 Interoperable Masks That Reduce Flow-Setting and Device-Switching Errors
  • 4.2.6 Procurement Demand for Low-Inventory, Multi-Configuration Mask Kits
• 4.3 Market Restraints
  • 4.3.1 Substitution by Nasal Cannulas and High-Flow Nasal Cannula Systems
  • 4.3.2 Reimbursement and Tender-Price Pressure in Homecare
  • 4.3.3 Material-Transition and Medical-Grade Resin Supply Exposure
  • 4.3.4 Fit, Seal, and Oxygen-Concentration Variability in Real-World Use
• 4.4 Value and Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porters Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS, VALUE AND VOLUME

• 5.1 Segmentation by Product Type
  • 5.1.1 Simple Oxygen Masks
  • 5.1.2 Rebreather Masks
  • 5.1.3 Venturi Masks
  • 5.1.4 Specialty Oxygen Masks
• 5.2 Segmentation by Material
  • 5.2.1 Polyvinyl Chloride
  • 5.2.2 Silicone
  • 5.2.3 Others (Rubber and Elastomer)
• 5.3 Segmentation by Application
  • 5.3.1 Respiratory Disorders
  • 5.3.2 Emergency & Critical Care
  • 5.3.3 Surgical Care
  • 5.3.4 Aerosol Therapy
• 5.4 Segmentation by End User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Homecare
  • 5.4.3 Emergency Services
  • 5.4.4 Other Healthcare Facilities
• 5.5 Segmentation by Distribution Channel
  • 5.5.1 Direct Sales
  • 5.5.2 Retail
  • 5.5.3 Online Stores
• 5.6 Segmentation by Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 South Korea
    • 5.6.3.5 Australia
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 Medline Industries, LP
  • 6.4.2 Teleflex Incorporated
  • 6.4.3 Intersurgical Ltd.
  • 6.4.4 Flexicare (Group) Limited
  • 6.4.5 Dynarex Corporation
  • 6.4.6 VYAIRE MEDICAL, INC.
  • 6.4.7 Ambu A/S
  • 6.4.8 Drive DeVilbiss Healthcare
  • 6.4.9 Besmed Health Business Corp.
  • 6.4.10 HEYER Medical AG
  • 6.4.11 BLS Systems Limited
  • 6.4.12 Cardinal Health, Inc.
  • 6.4.13 Becton, Dickinson and Company
  • 6.4.14 ICU Medical, Inc.
  • 6.4.15 Dragerwerk AG and Co. KGaA
  • 6.4.16 Fisher and Paykel Healthcare Limited
  • 6.4.17 Polymed Medical Devices
  • 6.4.18 GaleMed Corporation
  • 6.4.19 PFM medical AG
  • 6.4.20 Airways Surgical Pvt. Ltd.
  • 6.4.21 Armstrong Medical Ltd.
  • 6.4.22 Mercury Medical
  • 6.4.23 SunMed, LLC
  • 6.4.24 Convatec Group PLC
  • 6.4.25 ZOLL Medical Corporation
  • 6.4.26 Masimo Corporation
  • 6.4.27 Koninklijke Philips N.V.
  • 6.4.28 Medtronic plc
  • 6.4.29 ResMed Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment